Europe Newborn Screening Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Newborn screening is a health program for screening newborns right after birth to identify problems that affect child’s health in future. Newborns are more liable to infections, which occurs on their first day of life. Newborn screening contains series of test which helps to detect the diseases and diagnosis are preventing inborn disability and deaths. These programs will change from country to another depending on the surroundings and legal requirements for a screening test.

Europe Newborn Screening Market Segments Size & Growth:

Europe Newborn Screening Market is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by an increase in neonatal diseases, creating awareness on neonatal hereditary, funding by the government organisations, and advancement in technology. However, delays in hospitalisation, lack of advanced instruments hinder the growth of the Europenewborn screening market.

Europe Newborn Screening Market Segments Share:

Europe Newborn Screening Market is categorised into by test type which consists of hearing screening test, critical congenital heart disease test, and dry blood spot test. Critical congenital heart disease test has the most significant share because of increase in critical congenital heart defects. By product, Europenewborn screening market is segmented as pulse oximetry, newborn disorder screening instruments, hearing screening devices & accessories, reagents & assay kits.  Among all newborn disorder screening instruments are expected to have high growth rate during the forecast period 2018-2024, due to increase in adoption of the screening test. The technology is segregated into DNA based array, electrophoresis, hearing screen technology, pulse oximetry technology. DNA based array is expected to have the most extensive share in the market owing to rise in genetic disorders.

By Geography, Germany is dominating the protein expression market, and the growth in Europe is mainly attributed because of the increasing adoption of the screening test and to reduce healthcare cost. Furthermore, UK is witnessing the fastest growth during the forecast period, due to rising patients, healthcare expenditure, and government funding.

Europe Newborn Screening Market Segments Trends:

• Trivitron Healthcare begins ultisys digital radiography system for a broad range of clinical application including general radiography.
• In September 2017, Natus Medical acquired Integra LifeSciences to have some medical assets and to enter the market.
• Thermo Fisher Scientific Inc. has acquired Patheon to enter into the (CDMO)Contract Development and Manufacturing Organization market in May 2017.

EuropeNewborn Screening Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

• Covidien PLC
• Waters Corporation
• Zen Tech S.A.
• Thermo Fisher Scientific, Inc.
• Masimo Corporation Bio-Rad Laboratories